2025. THE ROLE OF ECULUZIMAB IN THE PROGNOSIS OF SHIGA TOXIN- ASSOCIATED HEMOLYTIC-UREMIC SYNDROME IN CHILDREN: A LITERATURE REVIEW. Editora Impacto Científico. (Nov. 2025), 97–106.